Merakee Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.92 Cr
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.10 Cr
- Revenue Growth -86.75%
- Profit Growth -5731.31%
- Ebitda -3727.32%
- Net Worth -9.76%
- Total Assets 203.42%
About Merakee Life Sciences
Merakee Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2020 (Four years and four months 13 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.92 Cr.
The company currently has active open charges totaling ₹23.10 Cr.
Sameer Patil, Sanjeev Patil, Bhushan Shitole, and Two other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300PN2020PTC195004
- Company No.
195004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Merakee Life Sciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Patil  | Director | 15-Oct-2020 | Current |
| Sanjeev Patil | Director | 15-Oct-2020 | Current |
| Bhushan Shitole | Director | 15-Oct-2020 | Current |
| Sharoon Shitole | Director | 17-Nov-2020 | Current |
| Seema Patil | Director | 17-Nov-2020 | Current |
Financial Performance of Merakee Life Sciences.
Merakee Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 86.75% decrease. The company also saw a substantial fall in profitability, with a 5731.31% decrease in profit. The company's net worth dipped by a decrease of 9.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merakee Life Sciences?
Unlock access to Merakee Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹23.10 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 23.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Sep 2022 | Hdfc Bank Limited | ₹23.10 Cr | Open |
How Many Employees Work at Merakee Life Sciences?
Unlock and access historical data on people associated with Merakee Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merakee Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merakee Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.